Concepedia

Publication | Open Access

Association Between Immune-Related Adverse Events and Survival in Patients with Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab

DOIFull Paper Access

39

Citations

31

References

2023

Year

Taito Fukushima, Manabu Morimoto, Satoshi Kobayashi, Makoto Ueno, Haruki Uojima, Hisashi Hidaka, Chika Kusano, Makoto Chuma, Kazushi Numata, Kota Tsuruya,
The Oncologist

Abstract

The development of irAEs was associated with increased survival in a real-world population of patients with advanced HCC treated with atezolizumab plus bevacizumab. Grade 1/2 irAEs were strongly correlated with PFS and OS.

References

YearCitations

Page 1